Article
Reclassification of Variants of Uncertain Significance in BRCA1, BRCA2, and PALB2: Implications for Clinical Decision-Making in Breast Cancer
2026-06-28
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> Germline pathogenic variants in high-penetrance breast cancer susceptibility genes, including BRCA1, BRCA2, and PALB2, play a pivotal role in risk assessment, therapeutic decision-making, and preventive strategies. The reclassification of VUS through standardized frameworks and emerging evidence is essential to enhance their clinical utility. <bold>Materials...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- df76bf28-17c4-5882-9cae-04e4c197d2b5
- DOI
- 10.21203/rs.3.rs-9924373/v1
